He M, Sibille E, Benjamin D, Toth M, Shippenberg T
Integrative Neuroscience Unit, Behavioral Neuroscience Branch, NIDA Intramural Research Program, 21224, Baltimore, MD, USA.
Brain Res. 2001 May 25;902(1):11-7. doi: 10.1016/s0006-8993(01)02271-5.
An involvement of serotonin (5-HT) 1A receptors in the etiology of psychiatric disorders has been suggested. Hypo-responsiveness of the 5-HT1A receptor is linked to anxiety and constitutive deletion of the 5-HT1A receptor produces anxiety-like behaviors in the mouse. Evidence that 5-HT1A receptor inactivation increases the therapeutic effects of antidepressants has also been presented. The present studies used in vivo microdialysis and homologous recombination techniques to examine the contribution of 5-HT1A autoreceptors to these effects. Basal and fluoxetine-evoked extracellular concentrations of 5-HT were quantified in the striatum, a projection area of dorsal raphe neurons (DRN), of wild-type (WT) and 5-HT1A receptor knock out (KO) mice. The density of 5-HT transporters was also determined. Basal 5-HT concentrations did not differ in WT and KO mice. Fluoxetine (10 mg/kg) increased 5-HT concentrations in both genotypes. This increase was, however, 2-fold greater in KO mice. In contrast, no differences in K(+)-evoked 5-HT concentrations were seen. Similarly, neither basal nor stimulation-evoked DA differed across genotype. Autoradiography revealed no differences between genotype in the density of 5-HT transporters or post-synaptic 5-HT2A receptors, an index of 5-HT neuronal activity. These experiments demonstrate that, under basal and KCl stimulated conditions, adaptive mechanisms in the 5-HT system compensate for the lack of 5-HT1A autoreceptor regulation of DRN. Furthermore, they suggest that the absence of release-regulating 5-HT1A autoreceptors in the DRN can not account for the anxiety phenotype of KO mice. The enhanced response to fluoxetine in KO mice is consistent with pharmacological studies and suggests that adaptive mechanisms that occur in response to 5-HT1A receptor deletion are insufficient to oppose increases in 5-HT concentrations produced by acute inhibition of the 5-HT transporter.
已有研究表明,5-羟色胺(5-HT)1A受体参与了精神疾病的病因。5-HT1A受体反应低下与焦虑有关,5-HT1A受体的组成性缺失会在小鼠中产生类似焦虑的行为。也有证据表明,5-HT1A受体失活会增强抗抑郁药的治疗效果。本研究采用体内微透析和同源重组技术,来检验5-HT1A自身受体对这些效应的作用。对野生型(WT)和5-HT1A受体敲除(KO)小鼠纹状体(中缝背核神经元(DRN)的投射区域)中5-HT的基础浓度和氟西汀诱发的细胞外浓度进行了定量分析。还测定了5-HT转运体的密度。WT和KO小鼠的基础5-HT浓度没有差异。氟西汀(10mg/kg)使两种基因型小鼠的5-HT浓度均升高。然而,这种升高在KO小鼠中是WT小鼠的2倍。相反,在K(+)诱发的5-HT浓度上未见差异。同样,基础状态和刺激诱发的多巴胺在不同基因型之间也没有差异。放射自显影显示,5-HT转运体或突触后5-HT2A受体(5-HT神经元活动的一个指标)的密度在不同基因型之间没有差异。这些实验表明,在基础状态和氯化钾刺激条件下,5-HT系统中的适应性机制可弥补DRN中5-HT1A自身受体调节的缺失。此外,这些实验表明,DRN中缺乏释放调节性5-HT1A自身受体并不能解释KO小鼠的焦虑表型。KO小鼠对氟西汀反应增强与药理学研究结果一致,提示5-HT1A受体缺失后出现的适应性机制不足以对抗5-HT转运体急性抑制所产生的5-HT浓度升高。